2016 October

Patients with non-small cell lung cancer whose disease&nbsp;has metastasized to the brain can do without whole-brain&nbsp;radiotherapy, according to a study published in&nbsp;<em>Lancet.</em>

Description of&nbsp;3 cases whereby significant septic complications occurred in the setting of abiraterone use that were associated with&nbsp;hypogammaglobulinemia.

An overview of the data and rationale that led to the approval of nivolumab and&nbsp;pembrolizumab for NSCLC, with an emphasis on specific patient&nbsp;populations likely to benefit from this approach and future&nbsp;directions for clinical research in this area.

In an interview, Yvonne Saenger, MD, discussed&nbsp;ongoing developments with immunotherapy in&nbsp;melanoma.